Evidence map›Paper›PMID 25746987›Full record

ArticleApplied and environmental microbiology2015

Metabolic Profiling of Geobacter sulfurreducens during Industrial Bioprocess Scale-Up.

Howbeer Muhamadali, Yun Xu, David I Ellis, J William Allwood, Nicholas J W Rattray, Elon Correa, Haitham Alrabiah, Jonathan R Lloyd, Royston Goodacre

Open access · bronzeAbstract read
In one paragraph

Article in Applied and environmental microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 32 citations in OpenAlex.

  1. Metabolic profiling of Escherichia coli under deuterium oxide-induced stress.Metabolomics : Official journal of the Metabolomic Society · 2026
    Article
  2. Metabolic profiling analysis of cytochrome bMetabolomics : Official journal of the Metabolomic Society · 2026
    Article
  3. Article
  4. Metabolic response of Klebsiella oxytoca to ciprofloxacin exposure: a metabolomics approach.Metabolomics : Official journal of the Metabolomic Society · 2024
    Article
  5. Article
  6. Article
  7. Metabolomics ofInternational journal of molecular sciences · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Reduction Kinetic of Water Soluble Metal Salts byFrontiers in microbiology · 2022
    Article
  12. Article
  13. Biomineralization of CuApplied and environmental microbiology · 2020
    Article
  14. Radiation Tolerance ofFrontiers in microbiology · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Targeted redox and energy cofactor metabolomics inBiotechnology for biofuels · 2017
    Article
  19. Article
  20. Metabolic analysis of the response ofMetabolomics : Official journal of the Metabolomic Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Howbeer MuhamadaliSchool of Chemistry, Manchester Institute of Biotechnology, University of Manchester, Manchester, United Kingdom.
Yun XuSchool of Chemistry, Manchester Institute of Biotechnology, University of Manchester, Manchester, United Kingdom.
David I EllisSchool of Chemistry, Manchester Institute of Biotechnology, University of Manchester, Manchester, United Kingdom.
J William AllwoodSchool of Chemistry, Manchester Institute of Biotechnology, University of Manchester, Manchester, United Kingdom.
Nicholas J W RattraySchool of Chemistry, Manchester Institute of Biotechnology, University of Manchester, Manchester, United Kingdom.
Elon CorreaSchool of Chemistry, Manchester Institute of Biotechnology, University of Manchester, Manchester, United Kingdom.
Haitham AlrabiahSchool of Chemistry, Manchester Institute of Biotechnology, University of Manchester, Manchester, United Kingdom.
Jonathan R LloydWilliamson Research Centre for Molecular Environmental Science, School of Earth, Atmospheric and Environmental Sciences, University of Manchester, Manchester, United Kingdom jon.lloyd@manchester.ac.uk roy.goodacre@manchester.ac.uk.
Royston GoodacreSchool of Chemistry, Manchester Institute of Biotechnology, University of Manchester, Manchester, United Kingdom jon.lloyd@manchester.ac.uk roy.goodacre@manchester.ac.uk.
University of Manchester · GB

Funding

Biotechnology and Biological Sciences Research Council BB/M017702/1
6 · The paper itself

Abstract

During the industrial scale-up of bioprocesses it is important to establish that the biological system has not changed significantly when moving from small laboratory-scale shake flasks or culturing bottles to an industrially relevant production level. Therefore, during upscaling of biomass production for a range of metal transformations, including the production of biogenic magnetite nanoparticles by Geobacter sulfurreducens, from 100-ml bench-scale to 5-liter fermentors, we applied Fourier transform infrared (FTIR) spectroscopy as a metabolic fingerprinting approach followed by the analysis of bacterial cell extracts by gas chromatography-mass spectrometry (GC-MS) for metabolic profiling. FTIR results clearly differentiated between the phenotypic changes associated with different growth phases as well as the two culturing conditions. Furthermore, the clustering patterns displayed by multivariate analysis were in agreement with the turbidimetric measurements, which displayed an extended lag phase for cells grown in a 5-liter bioreactor (24 h) compared to those grown in 100-ml serum bottles (6 h). GC-MS analysis of the cell extracts demonstrated an overall accumulation of fumarate during the lag phase under both culturing conditions, coinciding with the detected concentrations of oxaloacetate, pyruvate, nicotinamide, and glycerol-3-phosphate being at their lowest levels compared to other growth phases. These metabolites were overlaid onto a metabolic network of G. sulfurreducens, and taking into account the levels of these metabolites throughout the fermentation process, the limited availability of oxaloacetate and nicotinamide would seem to be the main metabolic bottleneck resulting from this scale-up process. Additional metabolite-feeding experiments were carried out to validate the above hypothesis. Nicotinamide supplementation (1 mM) did not display any significant effects on the lag phase of G. sulfurreducens cells grown in the 100-ml serum bottles. However, it significantly improved the growth behavior of cells grown in the 5-liter bioreactor by reducing the lag phase from 24 h to 6 h, while providing higher yield than in the 100-ml serum bottles.

Indexed as

BioreactorsFumaratesGas Chromatography-Mass SpectrometryGeobacterIndustrial MicrobiologyMetabolomicsNiacinamideOxaloacetic AcidPyruvic AcidFumaratesNiacinamideOxaloacetic AcidPyruvic Acid

Identifiers

PMID25746987
PMCPMC4407208
OpenAlexW2088541080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.